Pfizer said it has not received any reports of adverse events related to the drug till date. Former Takeda vaccine chief to lead new COVID antiviral venture Aerium Aerium Therapeutics, a venture-backed startup, on Tuesday announced industry veteran Rajeev Venkayya will lead the company and released data that showed its two experimental monoclonal antibodies neutralized coronavirus variants, including Omicron and its fast-spreading subvariant BA.2, in lab studies.
Initial pipeline comprised of two monoclonal antibodies that show broad and significant neutralization of emerging SARS-CoV-2 variants; data posted on BioRXiv.
(Reuters) - Here's what you need to know about the coronavirus right now: Shanghai COVID cases hit daily record China's financial hub Shanghai on Tues.
By Julie Steenhuysen CHICAGO (Reuters) - Aerium Therapeutics, a venture-backed startup, on Tuesday announced industry veteran Rajeev Venkayya will lea.